Search

everythinglearnresearchcommunity

for

Search:↓

Patients reduced searches for dermatology issues during COVID-19, indicating a need for better telehealth services.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

The COVID-19 pandemic increased some stress-related skin diseases but didn't affect others.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

During the COVID-19 pandemic, more people were diagnosed with stress-related skin conditions like acne and temporary hair loss.

Face mask-related injuries in U.S. emergency departments rose by 2400% during the COVID-19 pandemic, with most injuries being dermatitis and lacerations.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

The pandemic increased stress-related skin conditions and those affected by behavior changes.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.

During the COVID-19 lockdown, there were fewer cases of mild skin issues and more cases of stress-related skin conditions.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

Doctors should adjust how they treat men with prostate-related urinary problems during and after the COVID-19 pandemic.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

COVID-19 can cause skin issues like rashes and hair loss, which may last even after recovery.

COVID-19 may cause hair loss conditions like alopecia areata and telogen effluvium.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Telogen effluvium increased globally after COVID-19, especially in Asian and Latin regions.

The COVID-19 pandemic did not significantly change stress levels in preschoolers, but higher-income families' children showed higher stress.

COVID-19 reinfection may trigger alopecia areata.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

The review indicates that understanding of long COVID symptoms is still limited and better research is needed for diagnosis and treatment.

More people are seeing dermatologists for hair and scalp problems now than in the past.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

During the COVID-19 pandemic, some skin conditions became more common while others decreased.

Insulin resistance linked to obesity may increase COVID-19 severity.